ANTIMICROBIAL SUSCEPTIBILITY AND PREVALENCE OF EXTENDED SPECTRUM BETALACTAMASE (ESBL) AND METALLO BETALACTAMASE (MBL) AND ITS CO-EXISTENCE AMONG PSEUDOMONAS AERUGINOSA RECOVERED FROM OCULAR INFECTIONS
Keywords:
Antimicrobial resistance, Pseudomonas aeruginosa, Keratitis, Ocular infectionsAbstract
Objectives: To evaluate the changing trends in antimicrobial susceptibility rate and detection of ESBL and MBL among Pseudomonas aeruginosa isolated from various ocular infections over a 2 year periods with special reference to detection of ESBL and MBL co-existence among P aeruginosa recovered from ocular infections.
Methods: All ocular specimens, culture positive for P aeruginosa (n=110) isolated from clinically suspected patients were submitted to L &T Microbiology Research Centre, Chennai, Tamil Nadu, India. Culture, antimicrobial susceptibility testing and ESBL detection was performed by Standard methods. MBL production was screened by Carbapenem-EDTA combination disk method.
Results: Of the 3247 samples subjected to culture from August 2012– July 2014 by standard method 276 were positive for bacterial growth, thereby 8.5% of ocular infections mediated by bacterial pathogens. Out of 276 culture positives 110 (39.8%) Pseudomonas aeruginosa isolates recovered from ocular infections. The resistance rate for commonly used drugs against ocular infection includes Gentamycin [23.63%], Gatifloxacin [20.9%], Moxifloxacin [20%], Tobramycin [20%], ciprofloxacin [19.09%]. Totally 15 (13.63%) out of 110 isolates were identified as ESBL producer and 11 (10%) out of 110 isolates were identified as MBL producer by screening test, including 7 isolates have co-produced both ESBL and MBL enzymes and 4 isolates were only positive for MBL production.
Conclusion: Though fluoroquinolones remains a good choice for ocular Pseudomonal infection. Gradual emergence of resistance to fluoroquinolones and aminoglycosides also noted from this study. The emergence of ESBL, MBL and pandrug resistance among P aeruginosa from ocular infections is an alarm rational finding which necessitates the earlier detection of both ESBL and MBL production as individual or co-existence in ocular isolates, which may pave the way for appropriate therapy for sight threatening conditions like endophthalmitis.
Â
Downloads
References
Blanc DS, Petignat C, Janin B, Bille J, Francioli P. Frequency and molecular diversity of Pseudomonas aeruginosa upon admission and during hospitalization: a prospective epidemiologic study. Clin Microbiol Infect 1998;4:242-7.
Bonfiglio G, Laksai Y, Franchino L, Amicosante G, Nicoletti G. Mechanism of beta-lactam resistance amongst Pseudomonas aeruginosa isolated in an Italian survey. J Antimicrobe Chemother 1998;42:697-702.
Hossain MG, Saha S, Rahman MM, Singha JK, Mamun AA. Isolation, identification and antibiogram study of Pseudomonas aeruginosa from cattle in Bangladesh. J Vet Adv 2013;3(7):180-5.
Stapleton F, Carnt N. Contact lens-related microbial keratitis: how have epidemiology and genetics helped us with pathogenesis and prophylaxis. Eye 2012;26(2):185-93.
Sy A, Srinivasan M, Mascarenhas J, Lalitha P, Rajaraman R, Ravindran M, Acharya NR, et al. Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment. Invest Ophthalmol Visual Sci 2012;53(1):267-72.
Paterson DL, Bonomo RA. Extended-spectrum β-lactamases: a clinical update. Clin Microbiol Rev 2005;18(4):657-86.
Bharathi MJ, Ramakrishnan R, Shivakumar C, Meenakshi R, Lionalraj D. Etiology and antibacterial susceptibility pattern of community-acquired bacterial ocular infections in a tertiary eye care hospital in south India. Indian J Ophthalmol 2010;58(6):497.
Jayahar BM, Ramakrishnan R, Ramesh S, Murugan N. Extended-spectrum beta-lactamase-mediated resistance among bacterial isolates recovered from ocular infections. Ophthalmic Res 2011;47(1):52-6.
Paranjothi S, Dheepa R. Screening for multidrug resistance bacteria Pseudomonas aeruginosa in hospitalized patients in Hosur, Krishnagiri (dt). Int J Pharm Biosci 2010;1(3):1.
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk tests; Approved Standards, CLSI Document M2-A9, Wayne PA 2006;26:1.
Behera B, Mathur P, Das A, Kapil A, Sharma V. An evaluation of four different phenotypic techniques for detection of metallo-β-lactamase producing Pseudomonas aeruginosa. Indian J Med Microbiol 2008;26(3):233.
Peshattiwar PD, Peerapur BV. ESBL and MBL mediated resistance in Pseudomonas aeruginosa: An emerging threat to clinical therapeutics. J Clin Diagn Res 2011;5:1552-4.
Patel M, Lavingia B, Patel A, Patel K. Susceptibility trends of pseudomonas from ocular lesions. Gujarat Med J 2009;46.
Bharathi MJ, Ramakrishnan R, Meenakshi R, Shivakumar C, Raj DL. Analysis of the risk factors predisposing to fungal, bacterial & Acanthamoeba keratitis in south India. Indian J Med Res 2009;130(6):749-57.
Ibukun A, Tochukwu N, Tolu O. Occurrence of ESBL and MBL in clinical isolates of Pseudomonas aeruginosa From Lagos, Nigeria. J Am Sci 2007;3(4):81-5.
Diwivedi M, Mishra A, Singh RK, A Azim, AK Baronia, KN Prasad. The nosocomial cross–transmission of Pseudomonas aeruginosa between patients in a tertiary intensive care unit. Indian J Pathol Microbiol 2009;52(4):509-13.
Arya M, Arya P, Biswas D, Prasad R. The antimicrobial susceptibility pattern of the bacterial isolates from post operative wound infections. Indian J Pathol Microbiol 2005;48(2):266-9.
Ferguson D, Cahill OJ, Quilty B. Phenotypic, molecular and antibiotic resistance profiling of nosocomial Pseudomonas aeruginosa strains isolated from two Ir. Hospitals J Med 2007;1(1):201-10.
Haleem H, Kadhim J, Ilham T, Banyan A. Isolation of Pseudomonas aeruginosa from clinical cases and environmental samples, and analysis of its antibiotic resistant spectrum at hilla teaching hospital. Med J Babylon 2011;8:618-24.
Bharathi MJ, Ramakrishnan R, Vasu S, Palaniappan R. Aetiological diagnosis of microbial keratitis in South India-A study of 1618 cases. Indian J Med Microbiol 2002;20(1):19-24.
Aggarwal R, Chaudhari U, Bala K. Detection of extended–spectrum β lactamases in Psuedomonas aeruginosa. Indian J Pathol Microbiol 2008;51(2):222-4.
Chaudhari U, Bhaskar H, Sharma M. The Imipenem–EDTA disk method for the rapid identification of metallo β lactamase producing gram negative bacteria. Indian J Med Res 2008;127(2):406-7.
Picao RC, Poirel L, Gales AC, Nordmann P. The diversity of β-lactamases produced by ceftazidime-resistant pseudomonas aeruginosa isolates causing bloodstream infections in Brazil. Antimicrob Agents Chemother 2009;53(9):3908-13.
Jaykumar S, Appalraju B. The prevalence of multi and pan drug resistant Pseudomonas aeruginosa with respect to ESBL and MBL in a tertiary care hospital. Indian J Pathol Microbiol 2007;50(4):922-5.
Varaiya A, Kulkarni N, Kulkarni M, Bhalekar P, Dogra J. The incidence of metallo beta lactamase producing seudomonas aeruginosa among ICU patients. Indian J Med Res 2008;127:398-402.
Navneeth BV, Sridaran D, Sahay D, Belwadi M. A preliminary study on the metallo betalactamase producing Pseudomonas aeruginosa in hospitalised patients. Indian J Med Res 2002;112:264-7.